Cargando…
A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review
As one of the most severe forms of muscle dystrophy, Duchenne muscular dystrophy (DMD) results in progressive muscle wasting, ultimately resulting in premature death due to cardiomyopathy. In the many years of research, the solution to DMD remains palliative. Although numerous studies including clin...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984139/ https://www.ncbi.nlm.nih.gov/pubmed/35402409 http://dx.doi.org/10.3389/fbioe.2022.833833 |
_version_ | 1784682117338234880 |
---|---|
author | Chung Liang, Lam Sulaiman, Nadiah Yazid, Muhammad Dain |
author_facet | Chung Liang, Lam Sulaiman, Nadiah Yazid, Muhammad Dain |
author_sort | Chung Liang, Lam |
collection | PubMed |
description | As one of the most severe forms of muscle dystrophy, Duchenne muscular dystrophy (DMD) results in progressive muscle wasting, ultimately resulting in premature death due to cardiomyopathy. In the many years of research, the solution to DMD remains palliative. Although numerous studies including clinical trials have provided promising results, approved drugs, even, the therapeutic window is still minimal with many shortcomings to be addressed. Logically, to combat DMD that arose from a single genetic mutation with gene therapy made sense. However, gene-based strategies as a treatment option are no stranger to drawbacks and limitations such as the size of the dystrophin gene and possibilities of vectors to elicit immune responses. In this systematic review, we aim to provide a comprehensive compilation on gene-based therapeutic strategies and critically evaluate the approaches relative to its efficacy and feasibility while addressing their current limitations. With the keywords “DMD AND Gene OR Genetic AND Therapy OR Treatment,” we reviewed papers published in Science Direct, PubMed, and ProQuest over the past decade (2012–2021). |
format | Online Article Text |
id | pubmed-8984139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89841392022-04-07 A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review Chung Liang, Lam Sulaiman, Nadiah Yazid, Muhammad Dain Front Bioeng Biotechnol Bioengineering and Biotechnology As one of the most severe forms of muscle dystrophy, Duchenne muscular dystrophy (DMD) results in progressive muscle wasting, ultimately resulting in premature death due to cardiomyopathy. In the many years of research, the solution to DMD remains palliative. Although numerous studies including clinical trials have provided promising results, approved drugs, even, the therapeutic window is still minimal with many shortcomings to be addressed. Logically, to combat DMD that arose from a single genetic mutation with gene therapy made sense. However, gene-based strategies as a treatment option are no stranger to drawbacks and limitations such as the size of the dystrophin gene and possibilities of vectors to elicit immune responses. In this systematic review, we aim to provide a comprehensive compilation on gene-based therapeutic strategies and critically evaluate the approaches relative to its efficacy and feasibility while addressing their current limitations. With the keywords “DMD AND Gene OR Genetic AND Therapy OR Treatment,” we reviewed papers published in Science Direct, PubMed, and ProQuest over the past decade (2012–2021). Frontiers Media S.A. 2022-03-23 /pmc/articles/PMC8984139/ /pubmed/35402409 http://dx.doi.org/10.3389/fbioe.2022.833833 Text en Copyright © 2022 Chung Liang, Sulaiman and Yazid. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Chung Liang, Lam Sulaiman, Nadiah Yazid, Muhammad Dain A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review |
title | A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review |
title_full | A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review |
title_fullStr | A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review |
title_full_unstemmed | A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review |
title_short | A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review |
title_sort | decade of progress in gene targeted therapeutic strategies in duchenne muscular dystrophy: a systematic review |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984139/ https://www.ncbi.nlm.nih.gov/pubmed/35402409 http://dx.doi.org/10.3389/fbioe.2022.833833 |
work_keys_str_mv | AT chunglianglam adecadeofprogressingenetargetedtherapeuticstrategiesinduchennemusculardystrophyasystematicreview AT sulaimannadiah adecadeofprogressingenetargetedtherapeuticstrategiesinduchennemusculardystrophyasystematicreview AT yazidmuhammaddain adecadeofprogressingenetargetedtherapeuticstrategiesinduchennemusculardystrophyasystematicreview AT chunglianglam decadeofprogressingenetargetedtherapeuticstrategiesinduchennemusculardystrophyasystematicreview AT sulaimannadiah decadeofprogressingenetargetedtherapeuticstrategiesinduchennemusculardystrophyasystematicreview AT yazidmuhammaddain decadeofprogressingenetargetedtherapeuticstrategiesinduchennemusculardystrophyasystematicreview |